Regulatory Actions Needed For Gaps In Cancer Drug Info
Drug manufacturers are not able to provide Europeans with the required information to gauge the benefits and defects of oncology medicines. This is as...
A Fund Boost For World-First Nervous System Transplant Study
Griffith University, based in Australia, has gone on to conduct a world-first study when it comes to cell transplantation so as to repair nervous...
New Delivery Path Brings To Light Efficacy of Immunotherapy
Intrathecal (IT), intravenous (IV), and Nivolumab (anti-PD-1) immunotherapy were found to be safe and prolong life in a subset of melanoma individuals with leptomeningeal...
Nasal Spray Shows Its Effect Against New COVID Variants
Researchers have identified a molecule that is particularly successful in preventing sickness caused by all known forms of the SARS-CoV-2 virus when put nasally....
Mid-Point Regulatory Science Strategy Study Published By EMA
The European Medicines Agency (EMA) has released a paper summarizing its Regulatory Science Strategy (RSS) mid-point achievements through 2025. Originally released in March 2020,...
AADC Inadequacy To Be Handled By A Novel Gene Therapy
In the final draft guidance rolled out by the National Institute for Health and Care Excellence- NICE, a single-dose therapy, eladocagene exuparvovec, has been...
New Drug Explored For Epilepsy Gets $3M Funding In Australia
More than 150,000 Australians and 50 million people across the world are affected by epilepsy, with almost one-third finding it challenging to control the...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...